广发纳斯达克生物科技人民币(001092)

动态评分: 4.50分

投资组合

报告日期 名称 比例
2024-06-30 Phathom Pharmaceuticals Inc 0.05%
2024-06-30 Allogene Therapeutics Inc 0.05%
2024-06-30 iTeos Therapeutics Inc 0.05%
2024-06-30 Centessa Pharmaceuticals Plc ADR 0.05%
2024-06-30 Olema Pharmaceuticals Inc 0.05%
2024-06-30 Y-mAbs Therapeutics Inc 0.05%
2024-06-30 Third Harmonic Bio Inc 0.05%
2024-06-30 Replimune Group Inc 0.05%
2024-06-30 Adaptive Biotechnologies Corp 0.05%
2024-06-30 REGENXBIO Inc 0.05%
2024-06-30 Alector Inc 0.04%
2024-06-30 Fulcrum Therapeutics Inc 0.04%
2024-06-30 Oric Pharmaceuticals Inc 0.04%
2024-06-30 MaxCyte Inc 0.04%
2024-06-30 Editas Medicine Inc 0.04%
2024-06-30 GRAIL Inc 0.04%
2024-06-30 KalVista Pharmaceuticals Inc 0.04%
2024-06-30 EyePoint Pharmaceuticals Inc 0.04%
2024-06-30 OmniAb Inc 0.04%
2024-06-30 Voyager Therapeutics Inc 0.04%

投资模拟

公告&资料